{"id":"W2725020420","doi":"10.1200/jco.2017.35.15_suppl.2570","title":"A first in human phase I study of AZD8186, a potent and selective inhibitor of PI3K in patients with advanced solid tumours as monotherapy and in combination with the dual mTORC1/2 inhibitor vistusertib (AZD2014) or abiraterone acetate.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Rash; Adverse effect; Nausea; Toxicity; Pharmacology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001194095,0.001578657,0.001945385,0.0004656774,0.0005851689,0.001333947,0.0007864247,0.001308241,0.004540065],"category_scores_gemma":[0.0007395307,0.0006636894,0.001451945,0.000504833,0.0008447691,0.000910004,0.0004416273,0.003391116,0.001319579],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009472204,"about_ca_system_score_gemma":0.001522681,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009275264,"about_ca_topic_score_gemma":0.002734758,"domain_scores_codex":[0.9995297,0.0001852358,0.00002401881,0.00009539642,0.00005433062,0.000111222],"domain_scores_gemma":[0.9994633,0.00007679089,0.0000937123,0.00006391015,0.00004144763,0.0002608508],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4346423,0.1370924,0.0150594,0.002080165,0.003088148,0.00127059,0.0009945483,0.006847955,0.160346,0.0009190093,0.01944421,0.2182153],"study_design_scores_gemma":[0.2587877,0.690006,0.01901155,0.00007405704,0.0007686307,0.00111239,0.0001298262,0.001367164,0.01237185,0.0004846057,0.01582772,0.00005855043],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9718745,0.007907927,0.002330373,0.001115658,0.0002846729,0.005680225,0.00531839,0.0002875433,0.005200791],"genre_scores_gemma":[0.9705382,0.005257275,0.003684219,0.001734429,0.0002284804,0.003558974,0.007499719,0.00008021372,0.007418476],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004540065,"threshold_uncertainty_score":0.01518798,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03019073941445846,"score_gpt":0.4015944852564905,"score_spread":0.3714037458420321,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}